PAREXEL INTERNATIONAL CLINICAL RESEARCH PVT LTD

During the FY19-20, the Indian arm of the US-based clinical research organisation generated revenue worth Rs 13 crore, exhibiting a decline of 32 per cent in its business when compared to the revenue generation of Rs 19 crore in the previous fiscal. PAREXEL provides services to help life sciences and biopharmaceutical clients everywhere transform scientific discoveries into new treatments. From decentralized clinical trials to regulatory consulting services to leveraging real-world insights, its therapeutic, technical, and functional ability is underpinned by a deep conviction. Also, the company offers translational medicine services with a specialisation in earlystage biomarker strategy development and execution.